Pharmacist Salary in Philadelphia, PA 2026,
$148,740 Median | BLS + Market Data

Philadelphia pharmacists earn a BLS MSA median of $148,740/yr, or $71.51 an hour, across the Philadelphia-Camden-Wilmington metro, with a published band of $119,840 to $167,270. That is 7.7% above the Pennsylvania statewide median. The band is tight by health-profession standards because a PharmD gates entry and most large employers here pay on published grade scales.

Yes, by 7.7%. Philadelphia concentrates the state's academic health systems and sits inside a pharmaceutical corridor that competes for the same graduates, and both effects push the metro band above the statewide one. Pennsylvania's smaller markets have proportionally more community-pharmacy jobs, which is the lower-paying end of the profession almost everywhere.

In this metro more than most. Residency-trained, board-certified clinical pharmacists are what the region's academic medical centres hire for their specialty services, and those are the roles that reach the $167,270 top of the published band. A pharmacist who stays in community practice can still earn near the metro median, but the upper quarter is effectively closed without post-graduate training.

A Pennsylvania pharmacist licence from the State Board of Pharmacy: a PharmD from an accredited programme, the NAPLEX and the Pennsylvania MPJE law exam, plus documented internship hours. Licensure is statewide rather than municipal, and reciprocity with neighbouring states matters here because the metro crosses into New Jersey and Delaware, where separate licences are required.

Pennsylvania's flat 3.07% state income tax is low relative to the Northeast, but Philadelphia's city wage tax applies to anyone earning wages inside city limits, resident or not. Since most of the metro's highest-paying hospital pharmacy posts are in Center City and University City, the effective difference between a city job and a suburban one at the same grade is larger than the published band suggests.

Two forces stack. The metro's academic health systems run specialty services — transplant, oncology, cell therapy — that require board-certified clinical pharmacists, and greater Philadelphia's pharmaceutical industry recruits the same profile for medical affairs and drug safety. Hospitals therefore compete against industry salaries for retention, which lifts the whole institutional band above what patient volumes alone would support.

This is one blended estimate for a four-state MSA reaching Wilmington and South Jersey, so it averages markets with different licence regimes. It is also base pay: shift and weekend differentials, on-call compensation for specialty services, and the sign-on packages community chains use to fill hard shifts are all real income excluded from the median.

The gap between this metro's 10th and 90th percentiles is unusually small for a six-figure profession. That is a structural consequence of the PharmD requirement: there is no low-credential tier to pull the floor down, and no independent-practice or ownership route to pull the ceiling up for most pharmacists. Advancement in Philadelphia is therefore lateral into specialty practice or vertical into management, and both move a pharmacist a modest percentage rather than a multiple.